Aviragen Therapeutics (AVIR) Reports Q4 Loss of $0.15/Share

Go back to Aviragen Therapeutics (AVIR) Reports Q4 Loss of $0.15/Share
(NASDAQ: AVIR) Delayed: 5.38 -0.05 (0.92%)
Previous Close $5.43    52 Week High $2.00 
Open $5.43    52 Week Low $1.15 
Day High $5.59    P/E N/A 
Day Low $5.30    EPS $0.00 
Volume 27,978